Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €35.78 EUR
Change Today -1.49 / -4.00%
Volume 0.0
SGT On Other Exchanges
Symbol
Exchange
Berlin
As of 2:29 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher S. Boerner Ph.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

44$2,392,958
As of Fiscal Year 2014

Background*

Dr. Christopher S. Boerner, also known as Chris, Ph.D., served as an Executive Vice President of Commercial at Seattle Genetics Inc. since February 2014. Dr. Boerner served as Senior Vice President of Commercial at Seattle Genetics Inc. from March 2012 to February 2014. He served as a Vice President of Marketing at Seattle Genetics Inc., from December 2010 to March 2012. Prior to Seattle Genetics, he was with Dendreon Corporation from June 2010 to November 2010, where ...

Read Full Background

Corporate Headquarters*

21823 30th Drive SE
Bothell, Washington 98021

United States

Phone: 425-527-4000
Fax: 425-527-4001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Washington University, St. Louis
MA
Haas School of Business
PhD
Haas School of Business

Other Affiliations*

Annual Compensation*

Salary$408,133
Total Annual Compensation$408,133

Stock Options*

Restricted Stock Awards$1,228,140
All Other Compensation$9,087
Exercisable Options167,749
Exercisable Options Value$2,363,645
Unexercisable Options91,251
Unexercisable Options Value$297,375
Total Value of Options$2,661,020
Total Number of Options259,000

Total Compensation*

Total Annual Cash Compensation$417,220
Total Short Term Compensation$408,133
Other Long Term Compensation$1,237,227
Total Calculated Compensation$2,392,958
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGT:GR €35.78 EUR -1.49

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer and President
Ariad Pharmaceuticals Inc.
$1.4M
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr11.0M
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
52.4M
David T. Hung M.D.Founder, Chief Executive Officer, President and Executive Director
Medivation, Inc.
$787.5K
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$889.2K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.